Search results
Results from the WOW.Com Content Network
Phenylketonuria is inherited in an autosomal recessive fashion. PKU is an autosomal recessive metabolic genetic disorder. As an autosomal recessive disorder, two PKU alleles are required for an individual to experience symptoms of the disease. For a child to inherit PKU, both parents must have and pass on the defective gene. [17]
Phenylketonuria (PKU)-like symptoms, including more pronounced developmental defects, skin irritation, and vomiting, may appear when phenylalanine levels are near 20 mg/dL (1200 mol/L). [1] Hyperphenylalaninemia is a recessive hereditary metabolic disorder that is caused by the body's failure to convert phenylalanine to tyrosine as a result of ...
E.g., reduction of dietary protein remains a mainstay of treatment for phenylketonuria and other amino acid disorders; Dietary supplementation or replacement E.g., oral ingestion of cornstarch several times a day helps prevent people with glycogen storage diseases from becoming seriously hypoglycemic. Medications
Created Date: 8/30/2012 4:52:52 PM
Phenylketonuria: 1 in 12,000 Autosomal recessive polycystic kidney disease: 1 in 20,000 [17] Mucopolysaccharidoses: 1 in 25,000 Lysosomal acid lipase deficiency: 1 in 40,000 Glycogen storage diseases: 1 in 50,000 Galactosemia: 1 in 57,000 X-linked Duchenne muscular dystrophy: 1 in 5,000 Hemophilia: 1 in 10,000 Values are for liveborn infants
A common example of pleiotropy is the human disease phenylketonuria (PKU). This disease causes mental retardation and reduced hair and skin pigmentation , and can be caused by any of a large number of mutations in the single gene on chromosome 12 that codes for the enzyme phenylalanine hydroxylase , which converts the amino acid phenylalanine ...
Robert Guthrie, MD, Ph.D. (June 28, 1916 – June 24, 1995) was an American microbiologist, best known for developing the bacterial inhibition assay used to screen infants for phenylketonuria at birth, before the development of irreversible neurological damage. [1]
[1] [5] PAL has recently been studied for possible therapeutic benefits in humans afflicted with phenylketonuria. [6] It has also been used in the generation of L-phenylalanine as precursor of the sweetener aspartame. [7] The enzyme is a member of the ammonia lyase family, which cleaves carbon–nitrogen bonds.